Beijing Chunlizhengda Medical Instruments Co Ltd Working Capital to Net Assets Ratio
Beijing Chunlizhengda Medical Instruments Co Ltd working capital to net assets ratio. Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Working Capital to Net Assets ratio of 81.8% as of September 2025. Working capital of CN¥2.44 Billion (current assets of CN¥2.90 Billion minus current liabilities of CN¥458.17 Million) is measured against net assets of CN¥2.99 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
Working capital to net assets ratio of Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024. This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 81.8%, reflecting working capital of CN¥2.44 Billion against net assets of CN¥2.99 Billion CNY. See 688236 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Beijing Chunlizhengda Medical Instruments Co Ltd Working Capital to Net Assets Ratio by Year (2012–2024)
Beijing Chunlizhengda Medical Instruments Co Ltd working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Beijing Chunlizhengda Medical Instrument balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 81.3% | CN¥2.29 Billion | CN¥2.82 Billion | CN¥2.84 Billion | CN¥546.75 Million | ▲ +0.4 pp |
| 2023 | 80.9% | CN¥2.33 Billion | CN¥2.88 Billion | CN¥3.01 Billion | CN¥676.67 Million | ▲ +0.6 pp |
| 2022 | 80.3% | CN¥2.18 Billion | CN¥2.72 Billion | CN¥2.78 Billion | CN¥595.80 Million | ▼ -1.1 pp |
| 2021 | 81.3% | CN¥2.01 Billion | CN¥2.47 Billion | CN¥2.45 Billion | CN¥439.62 Million | ▼ -0.6 pp |
| 2020 | 81.9% | CN¥884.54 Million | CN¥1.08 Billion | CN¥1.25 Billion | CN¥367.66 Million | ▲ +4.5 pp |
| 2019 | 77.4% | CN¥624.34 Million | CN¥806.59 Million | CN¥935.40 Million | CN¥311.05 Million | ▼ -0.5 pp |
| 2018 | 77.9% | CN¥489.13 Million | CN¥628.14 Million | CN¥661.20 Million | CN¥172.07 Million | ▼ -6.2 pp |
| 2017 | 84.1% | CN¥452.59 Million | CN¥538.47 Million | CN¥530.21 Million | CN¥77.62 Million | ▲ +1.4 pp |
| 2016 | 82.6% | CN¥397.43 Million | CN¥480.91 Million | CN¥439.43 Million | CN¥41.99 Million | ▲ +1.9 pp |
| 2015 | 80.7% | CN¥341.92 Million | CN¥423.56 Million | CN¥379.58 Million | CN¥37.65 Million | ▲ +14.6 pp |
| 2014 | 66.1% | CN¥136.19 Million | CN¥205.92 Million | CN¥162.50 Million | CN¥26.31 Million | ▲ +0.7 pp |
| 2013 | 65.4% | CN¥117.63 Million | CN¥179.89 Million | CN¥132.70 Million | CN¥15.07 Million | ▲ +4.0 pp |
| 2012 | 61.4% | CN¥106.32 Million | CN¥173.17 Million | CN¥120.66 Million | CN¥14.34 Million | — |